Akkaraju Srinivas's Form 4 filing
Neurogene Inc. (NGNE) · filed Nov 27, 2024
- Accession no.
- 0001415889-24-027861
- Filed
- Nov 27, 2024, 4:39 PM ET
- Trade date
- Nov 26, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.26M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Akkaraju SrinivasCIK 0001253170 | 10% Owner |
| Samsara BioCapital, L.P.CIK 0001699737 | 10% Owner |
| Samsara BioCapital GP, LLCCIK 0001888829 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 26, 2024 | Common Stock | PPurchaseAcquired | +20,748 | $24.91 | +$516,832.68 | 1,689,105 | Indirect | |
| Nov 26, 2024 | Common Stock | PPurchaseAcquired | +10,803 | $26.01 | +$280,986.03 | 1,699,908 | Indirect | |
| Nov 26, 2024 | Common Stock | PPurchaseAcquired | +15,219 | $26.73 | +$406,803.87 | 1,715,127 | Indirect | |
| Nov 26, 2024 | Common Stock | PPurchaseAcquired | +2,000 | $27.50 | +$55,000 | 1,717,127 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.